Atlas Trials

A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Responded to Previous Hepatitis B Vaccination But Lost Antibody.

Clinical trial NCT00291980 · COMPLETED

Trial details

NCT number
NCT00291980
Sponsor
Henogen
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatitis B
Start date
2006-03-01
Primary completion
2007-10-01
Enrollment
185

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.